Clinical Trial Update: Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oxaliplatin plus docetaxel as first-line treatment for advanced non-small cell lung cancer was terminated, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2013-01-31